This company has shut down. Fifth Eye is no longer operating.
Explore the Startup GraveyardFifth Eye develops a medical device software that provides a view of a patient’s evolving hemodynamic trajectory.
Fifth Eye's investors include Cultivation Capital, Arboretum Ventures, Biosciences Research and Commercialization Center (BRCC), CancerX Startup Accelerator, MINTS.
Fifth Eye is headquartered in Ann Arbor, United States.
Fifth Eye develops a medical device software that provides a view of a patient’s evolving hemodynamic trajectory.
Fifth Eye is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Fifth Eye — Funding & Investors." VCBacked, February 17, 2025, https://www.vcbacked.co/company/fifth-eye. Accessed September 29, 2026.
VCBacked. (2025). Fifth Eye — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/fifth-eye
{{cite web |title=Fifth Eye — Funding & Investors |url=https://www.vcbacked.co/company/fifth-eye |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated